Skip to main content
SpringerLink
Log in

7-Geranyloxcycoumarin enhances radio sensitivity in human prostate cancer cells

  • Original Article
  • Published:
Molecular Biology Reports Aims and scope Submit manuscript

Abstract

Background

Prostate cancer is the second most prevalent and the fifth deadliest cancer among men worldwide. To improve radiotherapy outcome, we investigated the effects of 7-geranyloxycoumarin, also known as auraptene (AUR), on radiation response of prostate cancer cells.

Methods and results

PC3 cells were pretreated with 20 and 40 µM AUR for 24, 48 and 72 h, followed by X-ray exposure (2, 4 and 6 Gy). After 72 h recovery, cell viability was determined by alamar Blue assay. Flow cytometric analysis was performed to assess apoptosis induction, clonogenic assay was carried out to investigate clonogenic survival, and the expression of P53, BAX, BCL2, CCND1 and GATA6 was analyzed by quantitative polymerase chain reaction (qPCR). Cell viability assay indicated that toxic effects of radiation was enhanced by AUR, which was also confirmed by increased numbers of apoptotic cells and reduced amount of survival fraction. The qPCR results demonstrated significant induction of P53 and BAX, while the expression of BCL2, GATA6, and CCND1 was significantly downregulated.

Conclusion

The findings of the present study indicated, for the first time, that AUR improved radio sensitivity in prostate cancer cells, and thus, has the potential to be used in future clinical trials.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

All data generated or analyzed during this study are included in this article.

References

  1. Wang L, Lu B, He M, Wang Y, Wang Z, Du L (2022) Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health 10:811044

    Article  PubMed  PubMed Central  Google Scholar 

  2. Schaue D, McBride WH (2015) Opportunities and challenges of radiotherapy for treating cancer. Nat reviews Clin Oncol 12:527–540

    Article  Google Scholar 

  3. Hashemi R, Farahi M, Bagheri R, Iranshahi M, Torabinejad S, Gharedaghi S, Soleymanifard S (2021) In vitro study of Radiosensitivity Effects of Galbanic Acid on ovarian tumor cells (OVCAR-3 cell line). Nat Prod Commun 16:1934578X211046068

    CAS  Google Scholar 

  4. Dilalla V, Chaput G, Williams T, Sultanem K (2020) Radiotherapy side effects: integrating a survivorship clinical lens to better serve patients. Curr Oncol 27:107–112

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Chen HH, Kuo MT (2017) Improving radiotherapy in cancer treatment: promises and challenges. Oncotarget 8:62742

    Article  PubMed  PubMed Central  Google Scholar 

  6. Linam J, Yang L-X (2015) Recent developments in radiosensitization. Anticancer Res 35:2479–2485

    CAS  PubMed  Google Scholar 

  7. Wang H, Mu X, He H, Zhang X-D (2018) Cancer radiosensitizers. Trends Pharmacol Sci 39:24–48

    Article  PubMed  Google Scholar 

  8. Gong L, Zhang Y, Liu C, Zhang M, Han S (2021) Application of radiosensitizers in cancer radiotherapy. Int J Nanomed 16:1083

    Article  Google Scholar 

  9. Zhang Q-Y, Wang F-X, Jia K-K, Kong L-D (2018) Natural product interventions for chemotherapy and radiotherapy-induced side effects. Front Pharmacol 9:1253

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  10. Wu Y, Xu J, Liu Y, Zeng Y, Wu G (2020) A review on anti-tumor mechanisms of coumarins. Front Oncol 10:2720

    Article  Google Scholar 

  11. Tayarani-Najaran Z, Tayarani-Najaran N, Eghbali S (2021) A review of auraptene as an anticancer agent. Front Pharmacol 12:698352

  12. Salari H, Afkhami-Poostchi A, Soleymanifard S, Nakhaei-Rad S, Merajifar E, Iranshahi M, Matin MM, Rassouli FB (2020) Coadministration of auraptene and radiotherapy; a novel modality against colon carcinoma cells in vitro and in vivo. Int J Radiat Biol 96:1051–1059

    Article  CAS  PubMed  Google Scholar 

  13. Movaffagh J, Salari H, Merajifar E, Gholamhosseinian H, Shahroodi A, Iranshahi M, Rassouli FB (2021) 7-geranyloxycoumarin enhanced radiotherapy effects on human gastric adenocarcinoma cells. J Cancer Res Ther 17(4):1–6

  14. Askari M, Sahebkar A, Iranshahi M (2009) Synthesis and purification of 7-prenyloxycoumarins and herniarin as bioactive natural coumarins. Iran J Basic Med Res Sci 12(2):63–69

  15. Barsouk A, Padala SA, Vakiti A, Mohammed A, Saginala K, Thandra KC, Rawla P, Barsouk A (2020) Epidemiology, staging and management of prostate cancer. Med Sci 8:28

    CAS  Google Scholar 

  16. Rawla P (2019) Epidemiology of prostate cancer. World J Oncol 10:63

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Afshari AR, Roshan MK, Soukhtanloo M, Ghorbani A, Rahmani F, Jalili-Nik M, Vahedi MM, Hoseini A, Sadeghnia HR, Mollazadeh H (2019) Cytotoxic effects of auraptene against a human malignant glioblastoma cell line. Avicenna J phytomed 9:334

    CAS  Google Scholar 

  18. Epifano F, Genovese S, Miller R, Majumdar AP (2013) Auraptene and its effects on the re-emergence of colon cancer stem cells. Phytother Res 27:784–786

    Article  CAS  PubMed  Google Scholar 

  19. Charmforoshan E, Karimi E, Oskoueian E, Es-Haghi A, Iranshahi M (2019) Inhibition of human breast cancer cells (MCF-7 cell line) growth via cell proliferation, migration, and angiogenesis by auraptene of Ferula szowitsiana root extract. J Food Meas Charact 13:2644–2653

    Article  Google Scholar 

  20. Moussavi M, Haddad F, Rassouli FB, Iranshahi M, Soleymanifard S (2017) Synergy between auraptene, ionizing radiation, and anticancer drugs in colon adenocarcinoma cells. Phytother Res 31:1369–1375

    Article  CAS  PubMed  Google Scholar 

  21. Xiao X, Che L, Li Y, Peng R, Wang M, Xiao W, Pan F, Wang H (2022) Label-free observation of morphological alteration of irradiated-urothelial bladder carcinoma cells through digital holographic microscopy. Front Phys 10:925523

  22. Huang Q, Zhou Z, Yan F, Dong Q, Wang L, Sha W, Xu Q, Zhu X, Zhao L (2020) Low–dose X–ray irradiation induces morphological changes and cytoskeleton reorganization in osteoblasts. Exp Ther Med 20:283

    Google Scholar 

  23. Narayanan SA, Ford J, Zawieja DC (2019) Impairment of lymphatic endothelial barrier function by X-ray irradiation. Int J Radiat Biol 95:562–570

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Franken NA, Rodermond HM, Stap J, Haveman J, Van Bree C (2006) Clonogenic assay of cells in vitro. Nat Protoc 1:2315–2319

    Article  CAS  PubMed  Google Scholar 

  25. Pajonk F, Pajonk K, McBride WH (1999) Inhibition of NF-κB, clonogenicity, and radiosensitivity of human cancer cells. J Natl Cancer Inst 91:1956–1960

    Article  CAS  PubMed  Google Scholar 

  26. Zdrowowicz M, Datta M, Rychłowski M, Rak J (2022) Radiosensitization of PC3 prostate cancer cells by 5-thiocyanato-2′-deoxyuridine. Cancers 14:2035

  27. Hasegawa H, Yamada Y, Iha H, Tsukasaki K, Nagai K, Atogami S, Sugahara K, Tsuruda K, Ishizaki A, Kamihira S (2009) Activation of p53 by Nutlin-3a, an antagonist of MDM2, induces apoptosis and cellular senescence in adult T-cell leukemia cells. Leukemia 23:2090–2101

    Article  CAS  PubMed  Google Scholar 

  28. Basu A, Haldar S (1998) The relationship between Bcl2, bax and p53: consequences for cell cycle progression and cell death. Mol Hum Reprod 4:1099–1109

    Article  CAS  PubMed  Google Scholar 

  29. Saboor-Maleki S, Rassouli FB, Matin MM, Iranshahi M (2017) Auraptene attenuates malignant properties of esophageal stem-like cancer cells. Technol Cancer Res Treat 16:519–527

    Article  CAS  PubMed  Google Scholar 

  30. Mousavi SH, Davari A-S, Iranshahi M, Sabouri-Rad S, Najaran ZT (2015) Comparative analysis of the cytotoxic effect of 7-prenyloxycoumarin compounds and herniarin on MCF-7 cell line. Avicenna J phytomed 5:520

    CAS  Google Scholar 

  31. Moon JY, Kim H, Cho SK (2015) Auraptene, a major compound of supercritical fluid extract of phalsak (Citrus Hassaku Hort ex Tanaka), induces apoptosis through the suppression of mTOR pathways in human gastric cancer SNU-1 cells. Evid Based Complementary Alternat Med 2015:402385

  32. Krishnan P, Kleiner-Hancock H (2012) Effects of auraptene on IGF-1 stimulated cell cycle progression in the human breast cancer cell line, MCF-7. Int J breast cancer 2012:502092

  33. Lee JC, Shin EA, Kim B, Kim BI, Chitsazian-Yazdi M, Iranshahi M, Kim SH (2017) Auraptene induces apoptosis via myeloid cell leukemia 1‐mediated activation of caspases in PC3 and DU145 prostate cancer cells. Phytother Res 31:891–898

    Article  CAS  PubMed  Google Scholar 

  34. An J, Chervin A, Nie A, Ducoff H, Huang Z (2007) Overcoming the radioresistance of prostate cancer cells with a novel Bcl-2 inhibitor. Oncogene 26:652–661

    Article  CAS  PubMed  Google Scholar 

  35. Adamsen BL, Kravik L, De Angelis PM (2009) Cellular response to chemoradiotherapy, radiotherapy and chemotherapy in two colorectal cancer cell lines. Radiat Res 171:562–571

    Article  CAS  PubMed  Google Scholar 

  36. Drobnjak M, Osman I, Scher HI, Fazzari M, Cordon-Cardo C (2000) Overexpression of cyclin D1 is associated with metastatic prostate cancer to bone. Clin Cancer Res 6:1891–1895

    CAS  PubMed  Google Scholar 

  37. Zhou P, Jiang W, Zhang Y, Kahn SM, Schieren I, Santella RM, Weinstein IB (1995) Antisense to cyclin D1 inhibits growth and reverses the transformed phenotype of human esophageal cancer cells. Oncogene 11:571–580

    CAS  PubMed  Google Scholar 

  38. Arber N, Doki Y, Han EK, Sgambato A, Zhou P, Kim N-H, Delohery T, Klein MG, Holt PR, Weinstein IB (1997) Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res 57:1569–1574

    CAS  PubMed  Google Scholar 

  39. Tashiro E, Tsuchiya A, Imoto M (2007) Functions of cyclin D1 as an oncogene and regulation of cyclin D1 expression. Cancer Sci 98:629–635

    Article  CAS  PubMed  Google Scholar 

  40. Sun Z, Yan B (2020) Multiple roles and regulatory mechanisms of the transcription factor GATA6 in human cancers. Clin Genet 97:64–72

    Article  CAS  PubMed  Google Scholar 

  41. Cai W-s, Shen F, Li J-l, Feng Z, Wang Y-c, Xiao H-q, Xu B (2014) Activated protease receptor-2 induces GATA6 expression to promote survival in irradiated colon cancer cells. Arch Biochem Biophys 555:28–32

    Article  PubMed  Google Scholar 

Download references

Funding

This work was supported by the Vice-Chancellor for Research and Technology, Mashhad University of Medical Sciences (Grant NO.: 980632; Ethical code: IR.MUMS.MEDICAL.REC.1398.653) and Ferdowsi University of Mashhad, Mashhad, Iran.

Author information

Authors and Affiliations

  1. Department of Medical Biotechnology and Nanotechnology, Faculty of Medicine, Mashhad University of Medical Sciences, Mashhad, Iran

    Yasaman Abolhassani & Khadijeh Jamialahmadi

  2. Department of Biology, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran

    Sara Mirzaei, Masoud Nejabat & Seyedehsaba Talebian

  3. Medical Physics Research Center, Mashhad University of Medical Sciences, Mashhad, Iran

    Hamid Gholamhosseinian

  4. Biotechnology Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran

    Mehrdad Iranshahi & Khadijeh Jamialahmadi

  5. Novel Diagnostics and Therapeutics Research Group, Institute of Biotechnology, Ferdowsi University of Mashhad, Mashhad, Iran

    Fatemeh B. Rassouli

Authors
  1. Yasaman Abolhassani
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sara Mirzaei
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Masoud Nejabat
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Seyedehsaba Talebian
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Hamid Gholamhosseinian
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Mehrdad Iranshahi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Fatemeh B. Rassouli
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Khadijeh Jamialahmadi
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Yasaman Abolhassani: Methodology, Investigation, Software, Analysis and interpretation of data, Writing- Original Draft. Sara Mirzaei: Methodology & Investigation. Masoud Nejabat: Writing – Review & Editing. Seyedehsaba Talebian: Methodology & Investigation. Hamid Gholamhosseinian: Radiotherapy. Mehrdad Iranshahi: AUR Synthesis. Fatemeh B. Rassouli, and Khadijeh Jamialahmadi: Supervision, Conceptualization and Design, Funding Acquisition.

Corresponding authors

Correspondence to Fatemeh B. Rassouli or Khadijeh Jamialahmadi.

Ethics declarations

Competing interests

The authors have no relevant financial or non-financial interests to disclose.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Abolhassani, Y., Mirzaei, S., Nejabat, M. et al. 7-Geranyloxcycoumarin enhances radio sensitivity in human prostate cancer cells. Mol Biol Rep 50, 5709–5717 (2023). https://doi.org/10.1007/s11033-023-08439-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11033-023-08439-9

Keywords

Search

Navigation